Routine experimental system for defining conditions used in photodynamic therapy and fluorescence photodetection of (non-) neoplastic epithelia
Authors:
- 1 January 2001
- journal article
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 6 (2) , 151-159
Abstract
A common method to induce enhanced short-term endogenous porphyrin synthesis and accumulation in cell is the topical, systemic application of 5-aminolevulinic acid or one of its derivatives. This circumvents the intravenous administration of photosensitizers normally used for photodynamic therapy (PDT) of fluorescence photodetection. However, in the majority of potential medical indications, optimal conditions with respect to the porphyrin precursor or its pharmaceutical formulation have not yet been found. Due to ethical restrictions and animal right directives, the number of available test objects is limited. Hence, definition and use of nonanimal test methods are needed. Tissue and organ cultures are a promising approach in replacing cost intensive animal models in early stages of drug development. In this paper, we present a tissue culture, which can among others be used routinely to answer specific questions emerging in the field of photodynamic therapy and fluorescence photodetection. This technique uses mucosae excised from sheep paranasal sinuses or pig bladder, which is cultured under controlled conditions. It allows quasiquantitative testing of different protoporphyrin IX precursors with respect to dose-response curves and pharmacokinetics, as well as the evaluation of different incubation conditions and/or different drug formulations. Furthermore, this approach, when combined with the use of electron microscopy and fluorescence-based methods, can be used to quantitatively determine the therapeutic outcome following protoporphyrin IX-mediated PDT.Keywords
This publication has 44 references indexed in Scilit:
- 5‐Aminolaevulinic Acid (ALA) for the Fluorescence Detection of Bronchial TumorsDiagnostic and Therapeutic Endoscopy, 1999
- On the Evolution of Some Endoscopic Light Delivery Systems for Photodynamic TherapyEndoscopy, 1998
- Flow cytometry study of the role of superoxide anion and hydrogen peroxide in cellular photodestruction with 5‐aminolevulinic acid‐induced protoporphyrin IXPhotodermatology, Photoimmunology & Photomedicine, 1997
- Iontophoretic Delivery of ALA Provides a Quantitative Model for ALA Pharmacokinetics and PpIX Phototoxicity in Human SkinJournal of Investigative Dermatology, 1997
- Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancerJournal of Photochemistry and Photobiology B: Biology, 1996
- In-vitro investigation of ALA-induced protopoyphyrin IXJournal of Photochemistry and Photobiology B: Biology, 1996
- Early clinical experience with 5‐aminolevulinic acid for the photodynamic therapy of superficial bladder cancerBritish Journal of Urology, 1996
- Photodynamic Therapy with Topical Application of 5-Aminolevulinic Acid in the Treatment of Actinic Keratoses: An Initial Clinical StudyDermatology, 1996
- Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of miceJournal of Photochemistry and Photobiology B: Biology, 1995
- Topical Photodynamic Therapy in VerrucaeDermatology, 1995